Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Aspen Aerogels (ASPN) Non Operating Income (2016 - 2025)

Historic Non Operating Income for Aspen Aerogels (ASPN) over the last 13 years, with Q3 2025 value amounting to -$2.4 million.

  • Aspen Aerogels' Non Operating Income rose 9205.39% to -$2.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$9.8 million, marking a year-over-year increase of 7400.98%. This contributed to the annual value of -$39.4 million for FY2024, which is 126291.27% down from last year.
  • Latest data reveals that Aspen Aerogels reported Non Operating Income of -$2.4 million as of Q3 2025, which was up 9205.39% from -$3.1 million recorded in Q2 2025.
  • In the past 5 years, Aspen Aerogels' Non Operating Income registered a high of $3.7 million during Q3 2021, and its lowest value of -$30.1 million during Q3 2024.
  • For the 5-year period, Aspen Aerogels' Non Operating Income averaged around -$2.2 million, with its median value being -$860000.0 (2022).
  • Per our database at Business Quant, Aspen Aerogels' Non Operating Income surged by 760204.08% in 2021 and then tumbled by 343684.21% in 2023.
  • Aspen Aerogels' Non Operating Income (Quarter) stood at -$41000.0 in 2021, then surged by 239.02% to $57000.0 in 2022, then tumbled by 3436.84% to -$1.9 million in 2023, then tumbled by 85.38% to -$3.5 million in 2024, then skyrocketed by 32.16% to -$2.4 million in 2025.
  • Its Non Operating Income stands at -$2.4 million for Q3 2025, versus -$3.1 million for Q2 2025 and -$832000.0 for Q1 2025.